Potential cardiovascular risk factors in paediatric renal transplant recipients.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 16252106)

Published in Pediatr Nephrol on October 27, 2005

Authors

Jorge R Ferraris1, Lidia Ghezzi, Gabriel Waisman, Rafael T Krmar

Author Affiliations

1: Departmento de Pediatria, Universidad de Buenos Aires, Argentina. Jorge.ferraris@hospitalitaliano.org.ar

Articles cited by this

Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ (2000) 56.80

Banting lecture 1988. Role of insulin resistance in human disease. Diabetes (1988) 33.22

Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics (1996) 6.29

Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study. Lancet (2002) 3.16

Cardiovascular health in childhood: A statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation (2002) 2.96

Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol (2000) 1.90

Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study. J Am Soc Nephrol (2000) 1.64

Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol (2000) 1.60

Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. Am J Transplant (2004) 1.50

Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. Transplantation (1998) 1.35

A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. Transplantation (2002) 1.32

Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int (1998) 1.26

Changing trends in pediatric transplantation: 2001 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant (2003) 1.16

Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med (1988) 1.11

Cardiovascular morbidity and risk factors in renal transplant patients. Nephrol Dial Transplant (1999) 1.03

Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. Pediatr Nephrol (2002) 1.02

Post-transplant diabetes mellitus. The role of immunosuppression. Drug Saf (1997) 0.99

Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients. J Pediatr (2003) 0.93

Cardiovascular risk factors in renal transplant patients: cyclosporin A versus tacrolimus. J Am Soc Nephrol (2001) 0.93

Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression. J Am Soc Nephrol (2002) 0.89

Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk. Drugs (2004) 0.88

One-year glomerular filtration rate predicts graft survival in pediatric renal recipients: a randomized trial of tacrolimus vs cyclosporine microemulsion. Transplant Proc (2002) 0.86

Risk factors predicting chronic rejection of renal allografts. Transplantation (1994) 0.86

Use of anti-hypertensive medications and post-transplant renal allograft function in children. Pediatr Transplant (2000) 0.83

Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years. Transplantation (2001) 0.82

Tacrolimus vs. cyclosporine A as primary immunosuppression in pediatric renal transplantation: a NAPRTCS study. Pediatr Transplant (2003) 0.82

Risk factors for cardiovascular disease in pediatric renal transplant recipients. Pediatr Transplant (2004) 0.82

Pathomechanisms and the diagnosis of arterial hypertension in pediatric renal allograft recipients. Pediatr Nephrol (2004) 0.82

Hypertension and end-organ damage in pediatric renal transplantation. Pediatr Transplant (2004) 0.81

Renal sodium handling with cyclosporin A and FK506 after orthotopic liver transplantation. J Am Soc Nephrol (1995) 0.80

Tacrolimus based immunosuppression. J Nephrol (2004) 0.80

Hyperlipidaemia in renal transplantation--risk factor for long-term graft outcome. Eur J Clin Invest (1995) 0.79

Hypertension in young patients after renal transplantation: ambulatory blood pressure monitoring versus casual blood pressure. Am J Hypertens (1998) 0.78

Long-term reproducibility of routine ambulatory blood pressure monitoring in stable pediatric renal transplant recipients. Am J Hypertens (2005) 0.77

Long-term follow-up of renal function in recipients and donors following pediatric kidney transplantation. Pediatr Nephrol (2001) 0.75

Hypertension is associated with hyperlipidemia, coronary heart disease and chronic graft failure in kidney transplant recipients. Clin Nephrol (1999) 0.75

Articles by these authors

Carotid artery intima-media thickness and distensibility in children and adolescents: reference values and role of body dimensions. Hypertension (2013) 2.31

Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome. Nephrol Dial Transplant (2011) 1.24

Genetic screening in adolescents with steroid-resistant nephrotic syndrome. Kidney Int (2013) 1.21

Effect of education on blood pressure control in elderly persons: a randomized controlled trial. Am J Hypertens (2006) 1.21

Hypertension-linked mutation in the adducin alpha-subunit leads to higher AP2-mu2 phosphorylation and impaired Na+,K+-ATPase trafficking in response to GPCR signals and intracellular sodium. Circ Res (2004) 1.13

The 14-3-3 protein translates the NA+,K+-ATPase {alpha}1-subunit phosphorylation signal into binding and activation of phosphoinositide 3-kinase during endocytosis. J Biol Chem (2005) 1.01

Phosphorylation of adaptor protein-2 mu2 is essential for Na+,K+-ATPase endocytosis in response to either G protein-coupled receptor or reactive oxygen species. Am J Respir Cell Mol Biol (2006) 0.97

Comparison of plasma clearance of iohexol and urinary clearance of inulin for measurement of GFR in children. Am J Kidney Dis (2010) 0.95

Recent respiratory infection predicts atherothrombotic stroke: case-control study in a Buenos Aires healthcare system. Stroke (2009) 0.93

Renal-limited vasculitis in children: a single-center retrospective long-term follow-up analysis. Clin Nephrol (2013) 0.82

Factors associated with nonattendance at clinical medicine scheduled outpatient appointments in a university general hospital. Patient Prefer Adherence (2013) 0.82

ABPM vs office blood pressure to define blood pressure control in treated hypertensive paediatric renal transplant recipients. Pediatr Transplant (2007) 0.81

Renal transplantation in infants and small children. Pediatr Nephrol (2011) 0.80

Use of annual ABPM, and repeated carotid scan and echocardiography to monitor cardiovascular health over nine yr in pediatric and young adult renal transplant recipients. Pediatr Transplant (2011) 0.80

Twenty-four-hour ambulatory blood pressure profiles in liver transplant recipients. Pediatr Transplant (2004) 0.77

Response to intima-media thickness in children--need for more parameters. Hypertension (2014) 0.77

An observational cohort study of the effect of hypertension on the loss of renal function in pediatric kidney recipients. Am J Hypertens (2013) 0.77

IgA nephropathy associated with a novel N-terminal mutation in factor H. Eur J Pediatr (2010) 0.77

Narrowing the gap in hypertension: effectiveness of a complex antihypertensive program in the elderly. Dis Manag (2004) 0.76

Renal physiology in newborns and old people: similar characteristics but different mechanisms. Int Urol Nephrol (2004) 0.75

The efficacy of hypotonic and near-isotonic saline for parenteral fluid therapy given at low maintenance rate in preventing significant change in plasma sodium in post-operative pediatric patients: protocol for a prospective randomized non-blinded study. BMC Pediatr (2011) 0.75

Noninvasive hemodynamic assessment of the effect of mean arterial pressure on the amplitude of pulse pressure. Am J Hypertens (2005) 0.75

Hemodynamic significance of high brachial pulse pressure in young men. Clin Exp Hypertens (2004) 0.75

A study on strategies for improving growth and body composition after renal transplantation. Pediatr Nephrol (2010) 0.75

[Pneumocystis jiroveci infection in patients with and without HIVA comparison]. Rev Chilena Infectol (2015) 0.75

Hemodynamic circulatory patterns in young patients with predominantly diastolic hypertension. J Am Soc Hypertens (2013) 0.75

[Pneumocystis jiroveci infection in patients with and without HIV: A comparison]. Rev Chilena Infectol (2015) 0.75

[Delirium in elderly inpatients. An 18 month follow-up]. Medicina (B Aires) (2010) 0.75

Prevalence of hyperhomocysteinemia in an elderly population. Am J Hypertens (2002) 0.75

Screening for anti-factor B autoantibody in a patient with acute renal injury due to dense deposit disease. Clin Nephrol (2012) 0.75

The deep-breath test as a diagnostic maneuver for white-coat effect in hypertensive patients. J Am Board Fam Pract (2004) 0.75

[Clinical characteristics of adult patients with herpetic meningoencephalitis: a nested case control study]. Rev Chilena Infectol (2015) 0.75

[Internal Medicine Residencies in Argentina, 2008]. Medicina (B Aires) (2010) 0.75

Analysis of blood pressure in children and adolescents reporting siesta during ambulatory blood pressure monitoring. Blood Press Monit (2003) 0.75